It is well established that focusing on diversity in clinical trials is essential for developing therapies that are safe and effective for different patient populations.
New technologies are bringing into effect rapid change across the pharma industry, but no other aspect of the business is seeing innovation at the scale and speed of the clinical trial spac
In good news for patients living with chronic hand eczema (CHE), Leo Pharma – a company working to advance medical dermatology treatments – has unveiled positive topline results for i
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio